Clinical Study

Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol

Table 1

Protocol of incremental treatment for ultrarush*, rush§, and slow conventional therapy*.

     Group AGroup BGroup C

μg/doseCumulative μg/doseMinuteμg/doseCumulative μg/doseDayHourμg/doseCumulative μg/doseWeek
0.0010.00100.010.01100.020.021
0.010.011150.10.1120.040.062
0.040.0513011.1140.080.143
0.050.114523.1160.20.344
0.10.216035.11200.40.745
0.40.61753.59.6120.81.546
0.51.11903.513.11423.547
12.111051023.113047.548
46.111201538.112815.549
511.111351553.1141025.5410
1021.111502073.11402045.5411
4061.111652598.1124085.5412
50111.10118025123.11460145.5413
30153.115080225.5414
35188.112100325.5415
35223.114

*As reported in Patella et al. [22].
§As reported in Bilò et al. [23].